Follicular lymphoma grade IIIb, in remission is a subtype of non-Hodgkin lymphoma characterized by the proliferation of malignant follicle center cells. This condition is clinically significant as it indicates a more aggressive form of lymphoma that can lead to serious health complications. The ICD-10 Code C82.4A facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track treatment outcomes and resource utilization.
ICD-10 Code C82.4A represents Follicular lymphoma grade IIIb, in remission, a hematological malignancy marked by the presence of large, transformed follicle center cells. This code is used when documenting patients who have achieved remission from this aggressive lymphoma subtype, allowing for appropriate billing and clinical management. It is essential for healthcare providers to use this code accurately to reflect the patient's current health status and treatment history.
Follicular lymphoma grade IIIb, in remission, is a hematological malignancy that arises from B-lymphocytes and is characterized by a higher proliferation rate compared to lower grades of follicular lymphoma. This condition requires careful monitoring and management due to its potential for recurrence and transformation into more aggressive forms of lymphoma.
ICD-10 Code C82.4A is utilized in SOAP notes to document the patient's remission status, guiding clinical assessments and treatment plans. This code plays a crucial role in both acute and chronic care settings, ensuring that healthcare providers can accurately track the patient's progress and response to therapy.
In SOAP notes, ICD-10 Code C82.4A connects subjective patient reports and objective clinical findings to a formal diagnosis of Follicular lymphoma grade IIIb, in remission. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of Follicular lymphoma grade IIIb, in remission, focuses on monitoring for recurrence and managing any residual symptoms. Treatment strategies may include chemotherapy, immunotherapy, or watchful waiting.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C82.4A is critical for accurate billing in hospital, ER, or oncology settings, ensuring proper reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 99214 | Established patient office visit, moderate complexity. |
| 85025 | Complete blood count with differential. |
| 77014 | Ultrasound guidance for needle placement. |
| 36415 | Collection of venous blood by venipuncture. |
Common Questions About Using ICD-10 Code C82.4A for Follicular lymphoma grade IIIb, in remission
What does it mean for Follicular lymphoma to be in remission?
Remission indicates that the signs and symptoms of Follicular lymphoma grade IIIb have significantly decreased or are no longer detectable. This status is crucial for determining ongoing treatment and monitoring strategies.
How often should patients with Follicular lymphoma in remission be monitored?
Patients in remission should typically have follow-up appointments every 3 to 6 months to monitor for any signs of recurrence and to manage any residual symptoms.
Can Follicular lymphoma grade IIIb return after remission?
Yes, Follicular lymphoma grade IIIb can recur after remission. Regular monitoring is essential to detect any recurrence early and to initiate appropriate treatment.
What are the common treatments for Follicular lymphoma grade IIIb?
Common treatments include chemotherapy, immunotherapy, and sometimes radiation therapy. The choice of treatment depends on the patient's overall health and specific disease characteristics.
Clinical Notes
SOAP notes
DAP notes
AI medical notes